Multicenter, Randomized, Double-blind, Parallel, Active Control, Phase III Clinical Study to Assess the Efficacy and Safety of THVD-201 in Patients With Overactive Bladder Including an Open-label, Extension Study
Phase of Trial: Phase III
Latest Information Update: 15 Sep 2017
At a glance
- Drugs Tolterodine/pilocarpine (Primary)
- Indications Overactive bladder; Urge incontinence
- Focus Adverse reactions; Therapeutic Use
- Sponsors SK Chemicals
- 11 Jan 2017 Status changed from recruiting to completed.
- 29 Jun 2015 Status changed from planning to recruiting, as reported by ClinicalTrials.gov.
- 04 Apr 2013 New trial record